(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of -1.54% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.
Neogen's revenue in 2025 is $894,661,000.On average, 2 Wall Street analysts forecast NEOG's revenue for 2026 to be $177,730,315,496, with the lowest NEOG revenue forecast at $177,391,475,406, and the highest NEOG revenue forecast at $178,069,155,587. On average, 3 Wall Street analysts forecast NEOG's revenue for 2027 to be $181,430,623,045, with the lowest NEOG revenue forecast at $180,562,671,122, and the highest NEOG revenue forecast at $182,050,526,646.
In 2028, NEOG is forecast to generate $185,570,336,685 in revenue, with the lowest revenue forecast at $185,558,390,400 and the highest revenue forecast at $185,582,282,970.